|
1.
|
Yong H, Foody J, Linong J, et al: A
systematic literature review of risk factors for stroke in China.
Cardiol Rev. Sep 17–2012.(Epub ahead of print).
|
|
2.
|
Takagi T, Kato T, Sakai H and Nashimura Y:
Early neurologic improvement based on the National Institutes of
Health Stroke Scale score predicts favorable outcome within 30
minutes after undergoing intravenous recombinant tissue plasminogen
activator therapy. J Stroke Cerebrovasc Dis. 12:322–329. 2012.
|
|
3.
|
Arnold M, Schroth G, Nedeltchev K, et al:
Intra-arterial thrombolysis in 100 patients with acute stroke due
to middle cerebral artery occlusion. Stroke. 33:1828–1833. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Pera J, Undas A, Topor-Madry R, et al:
Fibrin clot properties in acute stroke: what differs cerebral
hemorrhage from cerebral ischemia? Stroke. 43:1412–1414. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Kuoppala M, Åkeson J, Svensson P, et al:
Risk factors for haemorrhage during local intra-arterial
thrombolysis for lower limb ischaemia. J Thromb Thrombolysis.
31:226–232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Alexandrov AV, Demchuk AM, Felberg RA, et
al: High rate of recanalization and dramatic clinical recovery
during tPA infusion when continuously monitored with 2-MHz
transcranial Doppler monitoring. Stroke. 31:610–614. 2000.
View Article : Google Scholar
|
|
7.
|
Röther J, Schellinger PD, Gass A, et al:
Effect of intravenous thrombolysis on MRI parameters and functional
outcome in acute stroke <6 hours. Stroke. 33:2438–2445.
2002.
|
|
8.
|
Restrepo L, Bang OY, Ovbiagele B, et al:
Impact of hyperlipidemia and statins on ischemic stroke outcomes
after intra-arterial fibrinolysis and percutaneous mechanical
embolectomy. Cerebrovasc Dis. 28:384–390. 2009. View Article : Google Scholar
|
|
9.
|
Farkas J, Hinrichs C, Cariaga T, et al:
Intra-arterial thrombolysis using r-TPA: Initial angiographic
outcomes. ASNR Proceedings. 93:80–81. 2002.
|
|
10.
|
Xiao L, Tong JJ and Shen J: Endoluminal
treatment for venous vascular complications of malignant tumors.
Exp Ther Med. 4:323–328. 2012.PubMed/NCBI
|
|
11.
|
Linfante I and Akkawi NM: Advances in
treatment of acute ischemic stroke. Curr Neurol Neurosci Rep.
6:28–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Nesbit GM, Luh G, Tien R and Barnwell SL:
New and future endovascular treatment strategies for acute ischemic
stroke. J Vasc Interv Radiol. 15:S103–S110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Xavier AR, Tiwari A, Purai N, et al:
Safety and efficacy of intracranial stenting for acute ischemic
stroke beyond 8 h of symptom onset. J Neurointerv Surg. 4:94–100.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Bergui M, Stura G, Daniele D, et al:
Mechanical thrombolysis in ischemic stroke attributable to basilar
artery occlusion as first-line treatment. Stroke. 37:145–150. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Fourth National Cerebrovascular Diseases
Conference: Guidelines for the diagnosis and treatment of cerebral
infarction. Chinese Journal of Neurology. 29:376–381. 1996.
|
|
16.
|
Guideline of Cerebrovascular Disease
Prevention and Treatment in China. Journal of Apoplexy and Nervous
Diseases. 23:4–8. 2006.
|
|
17.
|
Smith WS, Sung G, Starkman S, et al:
Safety and efficacy of mechanical embolectomy in acute ischemic
stroke: results of the MERCI trial. Stroke. 36:1432–1438. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Qureshi AI, Siddiqui AM, Suri M, Fareed K,
et al: Aggressive Mechanical Clot Disruption and Low-dose
Intra-arterial Third-generation Thrombolytic Agent for Ischemic
Stroke: A Prospective Study. Neurosurgery. 51:1319–1329. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Leary MC, Saver JL, Gobin YP, et al:
Beyond tissue plasminogen activator: mechanical intervention in
acute stroke. Ann Emerg Med. 41:838–846. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Barreto AD, Albright KC, Hallevi H, et al:
Thrombus burden is associated with clinical outcome after
intra-arterial therapy for acute ischemic stroke. Stroke.
39:3231–3235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kidwell CS, Saver JL, Carnado J, et al:
Predictors of hemorrhagic transformation in patients receiving
intra-arterial thrombolysis. Stroke. 33:717–724. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kase CS, Furlan AJ, Wechsler LR, et al:
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic
stroke: the PROACT II trial. Neurology. 57:1603–1610. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kikuchi K, Kawahara KI, Miura N, et al:
Secondary prevention of stroke: Pleiotropic effects of optimal oral
pharmacotherapy. Exp Ther Med. 4:3–7. 2012.PubMed/NCBI
|
|
24.
|
Kim SK, Yim SV and Lee BC: Association
between cytochrome P450 promoter polymorphisms and ischemic stroke.
Exp Ther Med. 3:261–268. 2012.PubMed/NCBI
|
|
25.
|
Christoforidis GA, Mohammad Y, Kehagias D,
et al: Angiographic assessment of pial collaterals as a prognostic
indicator following intra-arterial thrombolysis for acute ischemic
stroke. AJNR Am J Neuroradiol. 26:1789–1797. 2005.PubMed/NCBI
|
|
26.
|
Christoforidis GA, Slivka A, Mohammad Y,
et al: Size matters: hemorrhage volume as an objective measure to
define significant intracranial hemorrhage associated with
thrombolysis. Stroke. 38:1799–1804. 2007.
|
|
27.
|
Christoforidis GA, Slivka AP, Karakasis C,
et al: Hemorrhage rates and outcomes when using up to 100 mg
intra-arterial t-PA for thrombolysis in acute ischemic stroke.
Interv Neuroradiol. 16:297–2305. 2010.PubMed/NCBI
|
|
28.
|
Carpenter CR, Keim SM, Milne WK, et al:
Thrombolytic therapy for acute ischemic stroke beyond three hours.
J Emerg Med. 40:82–92. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Castaño C, Dorado L, Guerrero C, et al:
Mechanical thrombectomy with the Solitaire AB device in large
artery occlusions of the anterior circulation: a pilot study.
Stroke. 41:1836–1840. 2010.
|
|
30.
|
Zaidat OO, Wolfe T, Hussain SI, et al:
Interventional acute ischemic stroke therapy with intracranial
self-expanding stent. Stroke. 39:2392–2395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Machi P, Costalat V, Lobotesis K, et al:
Solitaire FR thrombectomy system: immediate results in 56
consecutive acute ischemic stroke patients. J Neurointerv Surg.
4:62–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Gralla J, Brekenfeld C, Mordasini P, et
al: Mechanical thrombolysis and stenting in acute ischemic stroke.
Stroke. 43:280–285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Levy EI, Mehta R, Gupta R, et al:
Self-expanding stents for recanalization of acute cerebrovascular
occlusions. AJNR Am J Neuroradiol. 28:816–822. 2007.PubMed/NCBI
|
|
34.
|
Castaño C, Serena J and Dávalos A: Use of
the new Solitaire (TM) AB device for mechanical thrombectomy when
Merci clot retriever has failed to remove the clot. A case report.
Interv Neuroradiol. 15:209–214. 2009.PubMed/NCBI
|
|
35.
|
Janjua N, El-Gengaihy A, Pile-Spellman J,
et al: Late endovascular revascularization in acute ischemic stroke
based on clinical-diffusion mismatch. AJNR Am J Neuroradiol.
30:1024–1027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Chalela JA, Kidwell CS, Nentwich LM, et
al: Magnetic resonance imaging and computed tomography in emergency
assessment of patients with suspected acute stroke: a prospective
comparison. Lancet. 369:293–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Natarajan SK, Snyder KV, Siddiqui AH, et
al: Safety and effectiveness of endovascular therapy after 8 hours
of acute ischemic stroke onset and wake-up strokes. Stroke.
40:3269–3274. 2009. View Article : Google Scholar : PubMed/NCBI
|
